Product image of Glucosi Baxter (Glucose) supplied by GNH India

Glucosi Baxter

Active Ingredient:
Glucose
Origin:
EU

Glucosi Baxter (Glucose)

Glucosi Baxter is an intravenous solution whose active ingredient is glucose. It is supplied as a sterile liquid for infusion, intended for use in clinical settings within the European Union. The product provides a source of carbohydrate energy and can be used for fluid and nutritional support when administered by healthcare professionals.

Manufacturer / TM Owner

Baxter Polska Sp Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucosi Baxter is indicated for several clinical situations where rapid carbohydrate provision or fluid replacement is required.

  • Treatment of hypoglycemia in patients unable to take oral glucose.
  • Nutritional support for patients receiving parenteral nutrition.
  • Fluid replacement in patients with dehydration or electrolyte imbalance.
  • Adjunct therapy during surgery or critical care to maintain blood glucose levels.
  • Support for patients with metabolic disorders requiring controlled glucose infusion.

Side Effects

Glucosi Baxter may be associated with a range of adverse reactions, most of which are related to the infusion process or the glucose content.

Common

  • Mild hyperglycemia or transient increase in blood glucose.
  • Local irritation at the infusion site.
  • Nausea or mild gastrointestinal discomfort.
  • Headache during rapid infusion.
  • Electrolyte shifts, such as mild hyponatremia.

Serious

  • Severe hyperglycemia leading to osmotic diuresis.
  • Allergic reaction or anaphylaxis to formulation components.
  • Volume overload causing pulmonary edema.
  • Metabolic acidosis in patients with impaired metabolism.
  • Severe electrolyte disturbances, such as hyperkalemia.

Precautions & Warnings

When using Glucosi Baxter, clinicians should consider several safety measures to minimize risk.

  • Assess blood glucose levels before and during infusion, especially in diabetic patients.
  • Monitor fluid balance to avoid volume overload.
  • Use caution in patients with renal or hepatic impairment.
  • Adjust infusion rate in individuals prone to electrolyte imbalances.
  • Ensure sterility of the infusion set to prevent infection.
  • Verify compatibility with other intravenous solutions before co‑administration.

Avoid Interactions

Glucosi Baxter can interact with other medications or solutions, influencing its safety and efficacy.

Avoid

  • Co‑administration with high‑dose insulin without close glucose monitoring.
  • Simultaneous infusion of solutions containing high concentrations of potassium or calcium, which may cause precipitation.

Use with caution

  • Concurrent use of diuretics that affect fluid and electrolyte status.
  • Medications that alter glucose metabolism, such as glucocorticoids.
  • Intravenous lipid emulsions, which may affect glucose utilization.
  • Drugs that increase the risk of hyperglycemia, like certain antipsychotics.

Frequently Asked Questions

Glucosi Baxter is used to provide a rapid source of glucose for energy, support nutritional needs, and replace fluids in patients who cannot take oral intake.

It is commonly administered for hypoglycemia, parenteral nutrition, fluid replacement during dehydration, and as part of peri‑operative care to maintain blood glucose levels.

Blood glucose should be measured before starting the infusion and periodically during treatment, especially in patients with diabetes or impaired glucose tolerance.

Patients with renal impairment should be monitored closely for fluid overload and electrolyte changes, and infusion rates may need adjustment.

Common side effects include mild hyperglycemia, local infusion site irritation, nausea, headache, and minor electrolyte shifts.

Serious reactions include severe hyperglycemia, allergic reactions such as anaphylaxis, pulmonary edema from volume overload, and significant electrolyte disturbances.

Compatibility should be confirmed before mixing; avoid mixing with high‑dose insulin or solutions containing high potassium or calcium concentrations.

Monitor fluid balance, blood glucose, and electrolytes closely; adjust infusion rates based on intra‑operative needs and patient response.

Interactions may occur with insulin, diuretics, glucocorticoids, and medications that affect glucose metabolism; use caution and monitor relevant parameters.

The solution should be stored according to the manufacturer’s instructions, typically at controlled room temperature, protected from light, and used before the expiration date.

Use in children should be guided by clinical judgment and appropriate dosing calculations performed by a qualified healthcare professional.

Glucosi Baxter is marketed in the EU as an intravenous carbohydrate solution; its specific prescription status depends on national regulations.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT